American College of Physicians, CECity, and Pfizer collaborate
to increase adult immunization rates

PHILADELPHIA, May 14, 2014 -- The American College of Physicians
(ACP), CECity, and Pfizer Inc. (NYSE:PFE) today announced a new
initiative designed to increase adult immunization rates by
assisting physicians and other health care providers in strongly
recommending appropriate vaccination and tracking adult
immunization rates for quality measurement and improvement. The
three organizations made the announcement during the annual
National Adult Influenza and Immunization Summit meeting being held
May 13-15 in Atlanta.

The goal of this public health initiative is to meet the
National Vaccine Advisory Committee's standards for adult
immunization. The standards call on all health care providers to
assess vaccine status at each visit, strongly recommend
vaccinations to patients, administer or refer for immunization, and
document vaccination. Current vaccination rates for recommended
vaccines in the U.S. fall far short of those goals, with all rates
well below 70 percent and fraught with racial and ethnic
disparities1.

"As a national organization of internists, ACP's internal
medicine physician specialists and their practice teams play a
critical role in increasing adult immunization rates," said Dr.
Robert Centor, Chair of ACP's Board of Regents and a practicing
internist. "Recommending and offering appropriate vaccinations is a
core component of preventive health care, leading to improved
public health, less suffering and fewer deaths from preventable
illnesses, and lower health care costs."

The program will encourage health care providers and practice
teams to engage in ACP's Adult Immunization Registry available
through CECity's MedConcert® portal, a cloud-based
performance improvement platform. With funding from Pfizer and the
experience and resources from the three organizations, the program
will be piloted in two states with the goal to broaden the effort
nationwide.

"Pfizer is working to raise immunization rates to help protect
against vaccine preventable diseases," said Freda Lewis-Hall,
Executive Vice President and Chief Medical Officer, Pfizer Inc. "By
bringing together tremendous expertise in health care, technology
and quality improvement, this collaboration can make great strides
to address the long-standing public health challenge of vaccinating
American adults."

Research shows that a physician recommendation is the strongest
predictor of vaccination. Although the tracking and improvement of
adult immunization rates has been encouraged through guidelines and
multiple incentives programs, including the meaningful use of
electronic health records, most physicians currently do not have
the information they need to close the gap and increase the number
of patients vaccinated.

"Our cloud platform enables the secure exchange of data and the
ability to cost-effectively convert it into actionable information
that physicians need to manage their patient populations and
improve patient care," said Simone Karp, RPh, Chief Business
Development Officer and CECity co-founder. "Through the use of
flexible community-wide registries linked to data networks and
measurable improvement tools, this collaboration represents a new
generation in quality improvement."

A national advisory group co-chaired by Dr. Bernard Rosof, CEO
of QHC Advisory Group and Dr. William Schaffner, Immediate
Past-President of the National Foundation for Infectious Diseases,
will oversee the program, which will incorporate documented
strategies for increasing adult immunization rates and existing ACP
resources.

About the American College of Physicians
The American College of Physicians is the largest
medical specialty organization and the second-largest physician
group in the United States. ACP members include 137,000 internal
medicine physicians (internists), related subspecialists, and
medical students. Internal medicine physicians are specialists who
apply scientific knowledge and clinical expertise to the diagnosis,
treatment, and compassionate care of adults across the spectrum
from health to complex illness. Follow ACP on Twitter and Facebook.

Pfizer Inc.: Working together for a healthier
world®
At Pfizer, we apply science and our global resources to bring
therapies to people that extend and significantly improve their
lives. We strive to set the standard for quality, safety and value
in the discovery, development and manufacture of health care
products. Our global portfolio includes medicines and vaccines as
well as many of the world's best-known consumer health care
products. Every day, Pfizer colleagues work across developed and
emerging markets to advance wellness, prevention, treatments and
cures that challenge the most feared diseases of our time.
Consistent with our responsibility as one of the world's premier
innovative biopharmaceutical companies, we collaborate with health
care providers, governments and local communities to support and
expand access to reliable, affordable health care around the world.
For more than 150 years, Pfizer has worked to make a difference for
all who rely on us. To learn more, please visit us at www.pfizer.com.

About CECityCECity is the
health care industry's leading cloud-based provider of social
enterprise platforms and services that address the "3 Ps" driven by
healthcare reform: Pay for Value Reporting, Performance
Improvement, and Professional Certification. CECity combines its
scalable registry, quality measurement, and analytics platform with
education and improvement interventions from world-class partners,
to help all stakeholders answer the most important question, "How
Do We Improve?" Leading organizations across healthcare, including
physician practices, ACOs, health systems, health plans,
pharmacies, certifying boards, professional societies and academic
medical centers, count on CECity to power their high stake
solutions for performance improvement, clinical quality registries,
professional development, Maintenance of Certification, medication
adherence, care coordination, population health informatics and
value-based reporting.